Zobrazeno 1 - 10
of 6 663
pro vyhledávání: '"antibody-mediated rejection."'
Publikováno v:
Indian Journal of Transplantation, Vol 18, Iss 3, Pp 327-329 (2024)
Atypical hemolytic uremic syndrome (aHUS) is a complement-mediated thrombotic microangiopathy (TMA) resulting from uncontrolled activation of the alternate complement pathway. It is necessary to distinguish a recurrent aHUS posttransplant from de nov
Externí odkaz:
https://doaj.org/article/a3e075de969b4c828d0995fe4f7813de
Publikováno v:
Transplantology, Vol 5, Iss 3, Pp 163-173 (2024)
Chronic kidney disease (CKD) represents a significant global epidemiological challenge, demanding considerable financial resources for treatment. Renal transplantation is the optimal approach for end-stage renal failure, being the most cost-effective
Externí odkaz:
https://doaj.org/article/6abe8a79331747f5b3a3ff72e1569814
Autor:
Devika Gupta, Lavan Singh, Sameer Kumar, Kanwaljeet Singh, Satish Mendonca, Tathagat Chatterjee
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 67, Iss 3, Pp 624-627 (2024)
Background: Heart transplantation has evolved as the only treatment option for patients with refractory heart failure. Case Presentation: We here, report two unusual complications that developed following cardiac transplant to which the recipients su
Externí odkaz:
https://doaj.org/article/9bc72a96030943c7b3f0219ad6b103da
Publikováno v:
Indian Journal of Transplantation, Vol 18, Iss 2, Pp 161-166 (2024)
Background and Aim: Thrombotic microangiopathy (TMA) is a disease of microvasculature, triggered by numerous immunological and nonimmunological factors. The aim of this study is to identify the incidence, etiology, and clinical characteristics of pos
Externí odkaz:
https://doaj.org/article/98f4143d94994d1abe37555962da5876
Publikováno v:
Indian Journal of Transplantation, Vol 18, Iss 2, Pp 101-108 (2024)
Antibody-mediated rejection (ABMR) remains a significant cause of allograft failure in patients with kidney transplantation. Despite successful strategies to treat ABMR, irreversible injury in the form of transplant glomerulopathy commonly manifests
Externí odkaz:
https://doaj.org/article/a5f31418a5da4b6d8a066bbe94c023e1
Autor:
Ga Young Heo, Minsun Jung, Honglin Piao, Hyun Jeong Kim, Hyung Woo Kim, Juhan Lee, Kyu Ha Huh, Beom Seok Kim, Jaeseok Yang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionABO-incompatible (ABOi) kidney transplantation (KT) has become an important option to overcome organ shortage. Plasmapheresis/rituximab-based desensitization therapy has successfully reduced anti-ABO antibody levels and suppressed antibod
Externí odkaz:
https://doaj.org/article/5a93b1834d5c44b4b26065e703128ac2
Autor:
Linda Lóczi, Réka P. Szabó, Rita Orbán-Kálmándi, Rebeka Hodossy-Takács, Anikó Szilvási, Zoltán Szalai, Gábor Nagy, Péter Antal-Szalmás, Balázs Nemes, Zsuzsa Bagoly
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionThe development of de novo anti-HLA donor specific antibodies (DSAs) is associated with poor outcomes in kidney transplant recipients. It is surmised that an interaction between DSAs and the graft endothelium cause tissue injury, however,
Externí odkaz:
https://doaj.org/article/980b1d6c772a4aa8947cc7d4641752f8
Autor:
Mathilde Chambon, Alice Koenig
Publikováno v:
Transplant International, Vol 37 (2024)
Chronic graft rejection represents a significant threat to long-term graft survival. Early diagnosis, understanding of the immunological mechanisms and appropriate therapeutic management are essential to improve graft survival and quality of life for
Externí odkaz:
https://doaj.org/article/cdec1a613f3540de938f31e89b9c1ab5
Autor:
Yuko Miwa, Kenta Iwasaki, Kenta Murotani, Manabu Okada, Takaharu Nagasaka, Yoshihiko Watarai, Asami Takeda, Masato Shizuku, Satoshi Ashimine, Kohei Ishiyama, Shoichi Maruyama, Takaaki Kobayashi
Publikováno v:
Transplant International, Vol 37 (2024)
In ABO blood group incompatible kidney transplantation (ABO-I), potential issues on acute antibody-mediated rejection (ABMR) remain to be solved. This study aimed to assess the risk factors of acute ABMR using recipient- or donor-derived specimens. Q
Externí odkaz:
https://doaj.org/article/5a0bb467f56443b499a6de906907a07c
Autor:
Alex Boshart, Stefan Petrovic, Mark Abovsky, Chiara Pastrello, Sofia Farkona, Kieran Manion, Slaghaniya Neupane, Maya Allen, Igor Jurisica, Ana Konvalinka
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionKidney transplantation is the optimal treatment for end-stage kidney disease; however, premature allograft loss remains a serious issue. While many high-throughput omics studies have analyzed patient allograft biospecimens, integration of
Externí odkaz:
https://doaj.org/article/25f638791fc6410b8dcddc5a55fa3642